NeurAxis Q2 net loss widens 23.4% to $2.09 million year over year; net sales more than double to $1.93 million year over year - NRXS News | RalliesNeurAxis Q2 net loss widens 23.4% to $2.09 million year over year; net sales more than double to $1.93 million year over year
N
NRXS• Q2 results improve sales but loss widens
- NeurAxis posted a GAAP net loss of USD 2.09 million for Q2 2026, widening 23.4% year over year.
- Net sales more than doubled to USD 1.93 million, up 115.7% year over year.
- Gross margin rose to 85.9%, up 2.3 percentage points from a year earlier.
- Cash and cash equivalents climbed to USD 8.32 million at June 30, 2026, from USD 4.97 million at Dec. 31, 2025.
- Sales growth was attributed to broader insurance coverage tied to IB-Stim’s Category I CPT code effective Jan. 1, 2026.
